BETA

Atrion

ATRI53

$457.640.00%$0.00

ATRI53

$457.64

0.00%$0.00

Performance History

Key Stats
Open	$457.60
Prev. Close	$457.64
EPS	10.62

Next Earnings Date	Sep 27, 2024

	LOW	HIGH
Day Range	457.60	457.97
52 Week Range	274.98	575.88

Ratios







EPS	10.62

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

Correlated Companies

Eli Lilly & Co

LLY74

Price$804.62

Perf. (24h)

arrow_drop_down2.01%-$16.57

Market Cap$738.87B

UnitedHealth Group

UNH71

Price$569.71

Perf. (24h)

arrow_drop_up1.79%$10.03

Market Cap$527.83B

Johnson & Johnson

JNJ62

Price$160.64

Perf. (24h)

arrow_drop_up0.62%$1.00

Market Cap$382.01B

AbbVie

ABBV62

Price$185.16

Perf. (24h)

arrow_drop_up1.64%$2.99

Market Cap$326.96B

About Atrion (ATRI)

Atrion Corp (ATRI) is a company in the healthcare sector that specializes in medical devices and components. With over 75 years of experience, Atrion has built a reputation for innovation and quality in the industry. The company's stock price history has shown steady growth over the years, reflecting its strong performance and market position. Investors can track the stock price and monitor its fluctuations to make informed investment decisions. Atrion Corp's stock quote provides real-time information on the current price of the stock, allowing investors to stay up-to-date with the latest market trends.

The stock market is influenced by various factors, and Atrion Corp is not immune to these trends. That's why it's important for investors to stay informed about the latest news related to the company. By regularly checking the Atrion Corp stock news, investors can gain valuable insights into the company's performance, upcoming product launches, and industry trends. This information can help investors make informed decisions about buying or selling Atrion Corp stock.

Websitecall_made

Sector: Healthcare
Industry: Medical Instruments & Supplies
CEO: Mr. David A. Battat
Headquarters: Allen
Employees: 722
Exchange: NASDAQ

Keep an eye on Atrion

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the market capitalization of Atrion (ATRI)?

Atrion (ATRI) has a market capitalization of $805.44M. The average daily trading volume is 23.1K, indicating the stock's liquidity and investor engagement.

help

What is Atrion's (ATRI) price per share?

The current price per share for Atrion (ATRI) is $457.65. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Atrion (ATRI)?

For Atrion (ATRI), the 52-week high is $575.88, which is 25.83% from the current price. The 52-week low is $274.98, the current price is 66.43% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Atrion (ATRI) a growth stock?

Atrion (ATRI) has shown an average price growth of 0.41% over the past three years. It has received a score of 36 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Atrion as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Atrion (ATRI) stock price performance year to date (YTD)?

As of the latest data, Atrion (ATRI) has a year-to-date price change of 16.38%. Over the past month, the stock has experienced a price change of 1.14%. Over the last three months, the change has been 14.71%. Over the past six months, the figure is 41.04%. Looking at a longer horizon, the five-year price change stands at -39.61%.

help

Is Atrion (ATRI) a profitable company?

Atrion (ATRI) has a net income of $19.41M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 36.84% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 11.5% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $169.33M, although specific revenue growth data is currently not available. The gross profit is $62.39M. Operating income is noted at $22.58M. Furthermore, the EBITDA is $37.49M.

News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SRDX, ATRI on Behalf of Shareholders - GlobeNewswire

6/7/2024

Zacks Initiates Coverage of Atrion With Neutral Recommendation

5/31/2024

The Zacks Analyst Blog Highlights JPMorganChase, Chevron, Cisco Systems, Atrion and The Eastern

5/30/2024

Top Analyst Reports for JPMorgan Chase, Chevron & Cisco

5/29/2024

Nordson (NDSN) to Acquire Atrion & Boost Medical Offerings

Atrion Corporation Enters Into Merger Agreement with Nordson Corporation

MERGERS AND ACQUISITIONS

5/28/2024

Atrion Corporation Enters Into Merger Agreement with Nordson Corporation

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Performance History

Score Breakdown

Welcome to Stocklytics

Analyst Forecast

Analyst Ratings

Correlated Companies

About Atrion (ATRI)

Keep an eye on Atrion

Frequently Asked Questions

What is the market capitalization of Atrion (ATRI)?

What is Atrion's (ATRI) price per share?

What is the 52-week high and low for Atrion (ATRI)?

Is Atrion (ATRI) a growth stock?

What is Atrion (ATRI) stock price performance year to date (YTD)?

Is Atrion (ATRI) a profitable company?

News

Sign up for our newsletter

Take Your Investments to a Whole New Level